2012
DOI: 10.1074/jbc.m112.387639
|View full text |Cite
|
Sign up to set email alerts
|

SMAD versus Non-SMAD Signaling Is Determined by Lateral Mobility of Bone Morphogenetic Protein (BMP) Receptors

Abstract: Background: BMP-2 signals via heteromeric complexes of transmembrane receptors (BMPRI and BMPRII) to induce SMAD and non-SMAD signaling. Results: BMPRI and BMPRII show distinct lateral mobility behaviors, essential for signaling specificity. Conclusion: SMAD and non-SMAD signaling is differentially affected by alterations in BMP receptor mobility. Significance: This demonstrates a regulatory mechanism for fine-tuning BMP signaling through localization and biophysical properties of BMP receptors on the plasma m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
50
1

Year Published

2013
2013
2018
2018

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 56 publications
(52 citation statements)
references
References 47 publications
1
50
1
Order By: Relevance
“…Such clustering is consistent with either the aggregation of plasmamembrane-localized AMHRII or the existence of AMHRII-rich membrane subcompartments. Ligand activation of downstream signaling pathways has been shown to be influenced by the localization of TGFb receptors to cholesterol-rich domains (Shapira et al, 2014) and by the degree of lateral mobility or confinement of BMP receptors into membrane microdomains (Guzman et al, 2012). Thus, there are likely to be significant consequences of the AMHRII localization pattern that we have elucidated in this study on its signaling output.…”
Section: Discussionmentioning
confidence: 83%
“…Such clustering is consistent with either the aggregation of plasmamembrane-localized AMHRII or the existence of AMHRII-rich membrane subcompartments. Ligand activation of downstream signaling pathways has been shown to be influenced by the localization of TGFb receptors to cholesterol-rich domains (Shapira et al, 2014) and by the degree of lateral mobility or confinement of BMP receptors into membrane microdomains (Guzman et al, 2012). Thus, there are likely to be significant consequences of the AMHRII localization pattern that we have elucidated in this study on its signaling output.…”
Section: Discussionmentioning
confidence: 83%
“…Although Foxd1 −/− kidneys are much smaller than wild-type kidneys, proliferation within cap mesenchyme does not differ significantly, indicating that the effect of BMP on progenitor proliferation is unchanged and suggesting that signaling through SMAD1/5 is specifically affected by DCN (Levinson et al, 2005). Factors governing signaling outcomes of BMP receptor activation are incompletely understood, but include receptor complex conformation at the cell surface, which may be strongly influenced by the extracellular environment (Guzman et al, 2012). Future studies of the molecular mechanism by which DCN acts on BMP ligands and receptors will explore the possibility that it does not simply inhibit BMP signaling, but redirects its outcome.…”
Section: Research Articlementioning
confidence: 99%
“…The bone morphogenetic protein (BMP) receptors (BMPRs) are transmembrane proteins and belong to the family of serine/threonine kinases that comprises BMPR type I and II. The confinement in lateral mobility and accumulation of signaling receptors in microdomains at the cell membrane is crucial not only for binding to the ligand, but also for activation of signaling cascades [5,6]. Additionally, the different modes of receptor oligomerization dictate the downstream signaling pathways and the resulting transcriptional responses [7,8].…”
Section: Introductionmentioning
confidence: 99%